62135-008-56 : NDC 2026 Code

62135-008-56 : Cholestyramine For Oral Suspension ( Cholestyramine For Oral Suspension )

Additionally :

You can get information about “62135-008-56” NDC code in 62135-008-56 in HTML format

HTML | 62135-008-56 in TXT (Plain Text) format

TXT | 62135-008-56 in PDF (Portable Document Format)

PDF | 62135-008-56 in XML format

XML formats.

NDC Code : 62135-008-56 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "62135-008-56",
    "PackageDescription": "378 g in 1 CAN (62135-008-56) ",
    "NDC11Code": "62135-0008-56",
    "ProductNDC": "62135-008",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Cholestyramine For Oral Suspension",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Cholestyramine For Oral Suspension",
    "DosageFormName": "POWDER",
    "RouteName": "ORAL",
    "StartMarketingDate": "19960815",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA074561",
    "LabelerName": "Chartwell RX, LLC",
    "SubstanceName": "CHOLESTYRAMINE",
    "StrengthNumber": "4",
    "StrengthUnit": "g/9g",
    "Pharm_Classes": "Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2023-01-11",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20230103",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}